ACHC
Price
$23.88
Change
-$1.33 (-5.28%)
Updated
Jun 23, 04:01 PM (EDT)
Capitalization
2.32B
42 days until earnings call
Intraday BUY SELL Signals
DVA
Price
$210.97
Change
+$1.29 (+0.62%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
13.46B
43 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACHC vs DVA

ACHC vs DVA Comparison Chart in %
View a ticker or compare two or three

Which Stock Would AI Choose? Acadia Healthcare (ACHC) vs. DaVita (DVA) Stock Comparison

Key Takeaways

  • Acadia Healthcare (ACHC) has delivered a robust year-to-date gain of approximately 79%, significantly outpacing DaVita (DVA)'s 36% advance, reflecting a strong rebound from recent lows.
  • ACHC recently beat Q1 earnings per share (EPS) estimates at $0.37 versus $0.28 expected, though shares declined post-release amid softer guidance outlook.
  • DVA demonstrates superior profitability with a trailing twelve-month (TTM) EPS of $9.51 and price-to-earnings (P/E) ratio of 16.25, contrasting ACHC's negative TTM EPS.
  • DVA's market capitalization stands at $10.2 billion, over four times larger than ACHC's $2.3 billion, underscoring greater scale in the healthcare sector.
  • Both stocks benefit from steady healthcare demand but face regulatory and volume risks; DVA approaches Q1 earnings with expected 20.5% EPS growth.

Introduction

Acadia Healthcare (ACHC) and DaVita (DVA) represent distinct niches within the healthcare services sector, with ACHC focusing on behavioral health and DVA dominating kidney dialysis. This comparison is particularly relevant for investors seeking exposure to defensive healthcare plays amid market volatility, as both companies exhibit resilience tied to essential medical services. Traders monitoring relative performance may find insights into momentum shifts, valuation contrasts, and sector-specific catalysts valuable for position sizing or rotation strategies in portfolios emphasizing long-term stability over cyclical swings.

ACHC Overview and Recent Performance

Acadia Healthcare (ACHC) operates a network of inpatient psychiatric facilities, residential treatment centers, and outpatient behavioral health services across the U.S. and Puerto Rico. In recent market activity, the stock has shown volatility but staged a sharp recovery, posting year-to-date gains near 79% from 52-week lows around $11.43. Following its Q1 2026 earnings release, ACHC reported revenue of $828.8 million, up 7.6% year-over-year, with adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) at $144.2 million and EPS beating estimates at $0.37. Sentiment has been influenced by capacity expansions and same-facility revenue growth of 7.3%, though shares dipped in response to full-year guidance projecting EPS of $1.35–$1.60, tempering optimism amid broader operational pressures.

DVA Overview and Recent Performance

DaVita (DVA) is a leading provider of kidney dialysis services for chronic kidney failure patients, operating centers nationwide alongside lab and integrated care offerings. Recent weeks have seen steady performance, with shares trading around $154 and year-to-date returns of 36% within a 52-week range of $101–$159.42. Positive momentum stems from resilient dialysis demand and analyst upgrades, including UBS raising its price target to $190 while maintaining a Buy rating. Upcoming Q1 earnings on May 5 anticipate 20.5% EPS growth to $2.41, supported by prior quarters' revenue beats, though stagnant treatment volumes and regulatory scrutiny have introduced caution in market positioning.

Trending AI Robots

Tickeron’s Trending AI Robots page curates the top-performing AI trading bots from its library of over 350 bots that trade thousands of tickers across diverse strategies, timeframes, and market conditions. Only the most suitable for current environments—selected for real-time signals, risk management, and superior metrics—earn a spot among the featured 25 trending agents. These bots showcase annualized returns ranging from 32% to 127%, win rates of 50–70%, profit factors up to 3.35, and average gains of 4–16%, spanning themes like semiconductors, data centers, industrials, and small caps with trade durations from minutes to days. Each employs unique AI/ML approaches, such as trend trading or volatility plays, enabling customization. Explore these high-conviction options to enhance your trading edge in today’s dynamic markets.

Head-to-Head Comparison

While both ACHC and DVA serve essential healthcare needs, their business models diverge: ACHC targets behavioral health with inpatient and outpatient facilities, vulnerable to reimbursement changes and capacity constraints, versus DVA’s focus on predictable dialysis volumes tied to end-stage renal disease prevalence. Growth drivers for ACHC include facility expansions amid rising mental health demand, contrasting DVA’s integrated kidney care and value-based arrangements. Recent momentum favors ACHC’s YTD surge but highlights volatility, while DVA offers steadier trends. Risk factors overlap in regulatory oversight and payer mix, with DVA facing dialysis-specific competition. Market sentiment leans toward DVA’s scale advantages, though ACHC’s smaller size enables nimbler positioning in underserved behavioral segments.

Tickeron AI Verdict

Tickeron’s AI currently leans toward DVA with higher probability due to its trend consistency, positive profitability metrics, larger market positioning, and anticipated earnings catalysts, positioning it favorably amid healthcare sector rotations despite ACHC’s impressive momentum rebound.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

VS
ACHC vs. DVA commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHC is a Hold and DVA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (ACHC: $25.20 vs. DVA: $209.68)
Brand notoriety: ACHC: Not notable vs. DVA: Notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: ACHC: 89% vs. DVA: 79%
Market capitalization -- ACHC: $2.32B vs. DVA: $13.46B
ACHC [@Hospital/Nursing Management] is valued at $2.32B. DVA’s [@Hospital/Nursing Management] market capitalization is $13.46B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $83.63B to $0. The average market capitalization across the [@Hospital/Nursing Management] industry is $4.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHC’s FA Score shows that 1 FA rating(s) are green whileDVA’s FA Score has 3 green FA rating(s).

  • ACHC’s FA Score: 1 green, 4 red.
  • DVA’s FA Score: 3 green, 2 red.
According to our system of comparison, DVA is a better buy in the long-term than ACHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHC’s TA Score shows that 5 TA indicator(s) are bullish while DVA’s TA Score has 4 bullish TA indicator(s).

  • ACHC’s TA Score: 5 bullish, 3 bearish.
  • DVA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ACHC is a better buy in the short-term than DVA.

Price Growth

ACHC (@Hospital/Nursing Management) experienced а +0.84% price change this week, while DVA (@Hospital/Nursing Management) price change was -0.03% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -0.10%. For the same industry, the average monthly price growth was +4.78%, and the average quarterly price growth was +27.33%.

Reported Earning Dates

ACHC is expected to report earnings on Aug 04, 2026.

DVA is expected to report earnings on Aug 05, 2026.

Industries' Descriptions

@Hospital/Nursing Management (-0.10% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DVA($13.5B) has a higher market cap than ACHC($2.32B). ACHC (20.21) and DVA (20.20) have similar P/E ratio . DVA YTD gains are higher at: 84.561 vs. ACHC (77.590). DVA has higher annual earnings (EBITDA): 2.71B vs. ACHC (-725.79M). DVA has more cash in the bank: 667M vs. ACHC (158M). ACHC has less debt than DVA: ACHC (2.67B) vs DVA (13.2B). DVA has higher revenues than ACHC: DVA (13.8B) vs ACHC (3.37B).
ACHCDVAACHC / DVA
Capitalization2.32B13.5B17%
EBITDA-725.79M2.71B-27%
Gain YTD77.59084.56192%
P/E Ratio20.2120.20100%
Revenue3.37B13.8B24%
Total Cash158M667M24%
Total Debt2.67B13.2B20%
FUNDAMENTALS RATINGS
ACHC vs DVA: Fundamental Ratings
ACHC
DVA
OUTLOOK RATING
1..100
1712
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
74
Overvalued
PROFIT vs RISK RATING
1..100
10042
SMR RATING
1..100
995
PRICE GROWTH RATING
1..100
437
P/E GROWTH RATING
1..100
1120
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACHC's Valuation (54) in the Medical Or Nursing Services industry is in the same range as DVA (74). This means that ACHC’s stock grew similarly to DVA’s over the last 12 months.

DVA's Profit vs Risk Rating (42) in the Medical Or Nursing Services industry is somewhat better than the same rating for ACHC (100). This means that DVA’s stock grew somewhat faster than ACHC’s over the last 12 months.

DVA's SMR Rating (5) in the Medical Or Nursing Services industry is significantly better than the same rating for ACHC (99). This means that DVA’s stock grew significantly faster than ACHC’s over the last 12 months.

DVA's Price Growth Rating (7) in the Medical Or Nursing Services industry is somewhat better than the same rating for ACHC (43). This means that DVA’s stock grew somewhat faster than ACHC’s over the last 12 months.

ACHC's P/E Growth Rating (11) in the Medical Or Nursing Services industry is in the same range as DVA (20). This means that ACHC’s stock grew similarly to DVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHCDVA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
51%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
68%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 9 days ago
66%
Declines
ODDS (%)
Bearish Trend 19 days ago
69%
Bearish Trend 16 days ago
56%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
65%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
ACHC
Daily Signal:
Gain/Loss:
DVA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SGDJ83.800.71
+0.85%
Sprott Junior Gold Miners ETF
RPV112.660.47
+0.42%
Invesco S&P 500® Pure Value ETF
EFAS21.42-0.05
-0.23%
Global X MSCI SuperDividend® EAFE ETF
QTPI25.50-0.07
-0.26%
North Square Rcim Tax-Advantaged Preferred And Income Securities ETF
EVYM50.73-0.15
-0.29%
Eaton Vance High Income Municipal ETF

ACHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHC has been loosely correlated with UHS. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHC jumps, then UHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHC
1D Price
Change %
ACHC100%
+1.33%
UHS - ACHC
35%
Loosely correlated
+1.04%
ASTH - ACHC
31%
Poorly correlated
+1.00%
THC - ACHC
30%
Poorly correlated
+3.58%
DVA - ACHC
30%
Poorly correlated
+0.85%
CON - ACHC
29%
Poorly correlated
-0.25%
More